Skip to main content
Top

07-05-2025 | Transthoracic Echocardiography | Image–Cardiology

Supravalvular aortic stenosis caused by compression of a pseudoaneurysm late after aortic root replacement

Authors: Masaru Yoshikai, Hisashi Sato, Motonori Uchino, Masahide Shichijo, Nobuhiko Koga

Published in: Journal of Medical Ultrasonics

Login to get access

Excerpt

We present a case of supravalvular aortic stenosis (SVAS) caused by compression of a pseudoaneurysm. A 69-year-old female presented with worsening dyspnea and chest pain. Ten years earlier, she experienced an acute aortic dissection and underwent emergency aortic root replacement with a mechanical valve, along with coronary artery bypass grafting to the right coronary artery (RCA) (Fig. 1a). A harsh systolic murmur was auscultated over a wide area of the precordium. No ischemic symptoms or signs were observed in the brain or upper extremities. Chest X-ray showed an increase in the cardiothoracic ratio compared to previous images, with congestion. An electrocardiogram did not show any ST-T changes. Transthoracic echocardiography (TTE) showed a slightly dilated left ventricle (LV), LV ejection fraction (LVEF) of 55%, hypokinesis of the basal inferior wall, and moderate mitral regurgitation (MR). Previous TTE measurements had shown an LVEF of 66% with no wall motion abnormalities. Although no abnormalities were noted in the aortic root (Fig. 1b) and in the prosthetic valve, the graft was compressed by a mass, resulting in SVAS (Fig. 1c–e). Contrast-enhanced CT revealed that the graft was compressed by the mass, leading to SVAS (Fig. 1f–h). The mass was enhanced, so the mass identified on TTE was confirmed as a pseudoaneurysm. The saphenous vein graft (SVG) was not opacified, but the RCA remained patent (Fig. 1g, h). During emergency surgery, blood flow entering the pseudoaneurysm was observed at the distal anastomosis of the graft, and the SVG was completely disrupted from the graft. The distal anastomosis was revised with a new graft, and a SVG was anastomosed between the graft and the RCA. Postoperative TTE showed a reduction in LV size, and the LVEF improved to 62%. Furthermore, the hypokinesis of the basal inferior wall and the MR resolved.
Fig. 1
The contrast-enhanced CT scan taken after the initial surgery shows the ascending aorta replaced with a prosthetic graft and a saphenous vein graft (SVG) to the right coronary artery (a). Transthoracic echocardiography reveals no abnormalities in the aortic root (b), but shows the graft is compressed and narrowed by a mass at its midportion (c). A mosaic flow is observed at the stenotic segment in the graft (arrow in d), with a peak pressure gradient of 24.5 mmHg at the same site (e). Contrast-enhanced CT shows that the pseudoaneurysm is compressing and narrowing the graft at it midportion (fh). The saphenous vein graft is not opacified (arrowhead in g, h), while the right coronary artery remained patent. SVG saphenous vein graft, RCA right coronary artery, LA left atrium, LV left ventricle, PV prosthetic valve
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Supravalvular aortic stenosis caused by compression of a pseudoaneurysm late after aortic root replacement
Authors
Masaru Yoshikai
Hisashi Sato
Motonori Uchino
Masahide Shichijo
Nobuhiko Koga
Publication date
07-05-2025
Publisher
Springer Nature Singapore
Published in
Journal of Medical Ultrasonics
Print ISSN: 1346-4523
Electronic ISSN: 1613-2254
DOI
https://doi.org/10.1007/s10396-025-01547-y

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest